[go: up one dir, main page]

MA30314B1 - Traitements contre le cancer - Google Patents

Traitements contre le cancer

Info

Publication number
MA30314B1
MA30314B1 MA31204A MA31204A MA30314B1 MA 30314 B1 MA30314 B1 MA 30314B1 MA 31204 A MA31204 A MA 31204A MA 31204 A MA31204 A MA 31204A MA 30314 B1 MA30314 B1 MA 30314B1
Authority
MA
Morocco
Prior art keywords
against cancer
treatments against
oxaliplatin
liposomes
relates
Prior art date
Application number
MA31204A
Other languages
English (en)
Inventor
Parthenios Boulikas
Original Assignee
Parthenios Boulikas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parthenios Boulikas filed Critical Parthenios Boulikas
Publication of MA30314B1 publication Critical patent/MA30314B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un liposome comprenant de l'oxaliplatine encapsulé et des procédés d'obtention d'oxaliplatine encapsulé. L'invention concerne également des liposomes comprenant de l'oxaliplatine et un autre médicament anticancéreux. Les liposomes de l'invention sont utiles pour les traitements contre le cancer.
MA31204A 2006-03-03 2008-09-02 Traitements contre le cancer MA30314B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20060100144A GR20060100144A (el) 2006-03-03 2006-03-03 Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene

Publications (1)

Publication Number Publication Date
MA30314B1 true MA30314B1 (fr) 2009-04-01

Family

ID=38325437

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31204A MA30314B1 (fr) 2006-03-03 2008-09-02 Traitements contre le cancer

Country Status (17)

Country Link
US (1) US20090053302A1 (fr)
EP (1) EP2001441A2 (fr)
JP (1) JP2009528340A (fr)
KR (1) KR20090023548A (fr)
CN (1) CN101522172A (fr)
AU (1) AU2007220263A1 (fr)
BR (1) BRPI0707059A2 (fr)
CA (1) CA2644566A1 (fr)
EA (1) EA200801912A1 (fr)
GR (1) GR20060100144A (fr)
MA (1) MA30314B1 (fr)
MX (1) MX2008011263A (fr)
NO (1) NO20083927L (fr)
RS (1) RS20080388A (fr)
TN (1) TNSN08345A1 (fr)
WO (1) WO2007099377A2 (fr)
ZA (1) ZA200807934B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
KR20080094473A (ko) * 2007-04-20 2008-10-23 한국화학연구원 음이온성 지질나노입자 및 이의 제조방법
CN101969963A (zh) * 2008-01-28 2011-02-09 那野伽利阿株式会社 医药组合物或组合剂
TWI468188B (zh) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
CA2753844A1 (fr) * 2008-03-05 2009-09-11 Vicus Therapeutics, Llc Compositions et procedes pour des therapies de la mucosite et d'oncologie
EP2123258A1 (fr) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes pour l'administration de médicaments
WO2010138550A1 (fr) * 2009-05-27 2010-12-02 Northeastern University Véhicules de nanoadministration conjugués
WO2011034394A2 (fr) * 2009-09-21 2011-03-24 주식회사 중외제약 Nanoparticules d'oxaliplatine et leur procédé de préparation
JP5817053B2 (ja) * 2010-04-02 2015-11-18 国立大学法人 千葉大学 腫瘍特異性を有するリポソーム
CN102133176B (zh) * 2011-03-22 2012-09-05 济南宏瑞创博医药科技开发有限公司 一种奥沙利铂胶束制剂及其制备方法及应用
JP5378469B2 (ja) * 2011-08-11 2013-12-25 学校法人 日本歯科大学 医療用薬剤
EP2883542B1 (fr) 2012-08-10 2019-05-01 Taiho Pharmaceutical Co., Ltd. Dispersion aqueuse de liposome encapsulant un oxaliplatine stable, et procédé de stabilisation
KR20150044838A (ko) * 2012-08-13 2015-04-27 레귤론, 인코퍼레이티드. 리포플라틴을 이용한 암 치료방법
MA37931A1 (fr) * 2012-08-13 2016-07-29 Teni Boulikas Procédés améliorés permettant de traiter un cancer avec une toxicité rénale réduite
CA2883703C (fr) 2012-09-04 2021-10-19 Eleison Pharmaceuticals, Llc Prevention de la rechute du cancer pulmonaire avec un complexe lipide/cisplatine
EA023757B1 (ru) * 2012-12-24 2016-07-29 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы оксалиплатина
CA2903234C (fr) * 2013-03-13 2018-08-28 Mallinckrodt Llc Compositions d'oxaliplatine liposomal pour la cancerotherapie
AU2014245147B2 (en) * 2013-03-27 2017-08-31 Les Laboratoires Servier Antitumor agent including low-dose irinotecan hydrochloride hydrate
CN103622912B (zh) * 2013-12-05 2016-02-24 常州金远药业制造有限公司 盐酸多柔比星-多西他赛或紫杉醇脂质体制剂及其制备方法
CA2976526A1 (fr) * 2015-02-13 2016-08-18 Trendmed Co., Ltd. Compositions et procedes de traitement de tumeur utilisant des nanoparticules
CA2977397A1 (fr) 2015-03-03 2016-09-09 Cureport, Inc. Formulations pharmaceutiques liposomales a double charge
EP3265059A4 (fr) 2015-03-03 2018-08-29 Cureport Inc. Formulations pharmaceutiques liposomales en combinaison
KR101687735B1 (ko) * 2015-09-18 2016-12-19 서울대학교 산학협력단 신규의 동결건조보조제 및 새로운 인지질 용해용 혼합용매를 이용한 리포좀 동결분체의 제조방법
US20190307690A1 (en) * 2016-05-03 2019-10-10 The American University In Cairo Liposomal Delivery Systems for Oxaliplatin and in Dual Drug Delivery in Combination with Chemo-sensitizing and Chemo-therapeutic agents
US10940112B2 (en) 2016-05-04 2021-03-09 L.E.A.F. Holdings Group Llc Targeted liposomal gemcitabine compositions and methods thereof
CN106074379B (zh) * 2016-07-11 2019-01-25 中国科学院上海药物研究所 聚乙二醇化奥沙利铂前药及其制备方法和用途
CN112656764B (zh) * 2020-12-28 2022-09-02 吉林大学 一种紫杉醇铂类共载靶向长循环脂质体及应用
CN114814023B (zh) * 2022-04-24 2024-07-30 江苏省中医院 脂质分子在作为胃癌化疗药耐药的预测性标志物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060080A (en) * 1990-07-16 2000-05-09 Daiichi Pharmaceutical Co., Ltd. Liposomal products
CA2046997C (fr) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomes
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
AU2001275423B2 (en) * 2000-06-09 2007-01-11 Regulon, Inc. Encapsulation of polynucleotides and drugs into targeted liposomes
CA2383259A1 (fr) * 2002-04-23 2003-10-23 Celator Technologies Inc. Composes synergiques
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
JP3415131B1 (ja) * 2002-06-03 2003-06-09 メビオファーム株式会社 リポソーム製剤
BRPI0313191A2 (pt) * 2002-08-02 2016-11-08 Transave Inc composição e processo para produzir um agregado de platina e formulação farmacêutica
WO2004098524A2 (fr) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Complexes de platine a lipides et leurs procedes d'utilisation
WO2005000266A2 (fr) * 2003-05-22 2005-01-06 Neopharm, Inc. Formulations liposomales combinees

Also Published As

Publication number Publication date
BRPI0707059A2 (pt) 2011-04-19
CN101522172A (zh) 2009-09-02
AU2007220263A1 (en) 2007-09-07
NO20083927L (no) 2008-09-15
WO2007099377A3 (fr) 2008-04-17
CA2644566A1 (fr) 2007-09-07
TNSN08345A1 (en) 2009-12-29
EA200801912A1 (ru) 2009-02-27
JP2009528340A (ja) 2009-08-06
MX2008011263A (es) 2008-12-12
RS20080388A (sr) 2009-07-15
ZA200807934B (en) 2009-11-25
GR20060100144A (el) 2007-10-17
WO2007099377A2 (fr) 2007-09-07
KR20090023548A (ko) 2009-03-05
US20090053302A1 (en) 2009-02-26
EP2001441A2 (fr) 2008-12-17

Similar Documents

Publication Publication Date Title
MA30314B1 (fr) Traitements contre le cancer
MX2007010996A (es) Nuevas composiciones de liposomas.
IL173052A0 (en) Lipid encapsulated interfering rna
IL173478A0 (en) Form of administration secured against misuse
EP1599196A4 (fr) Polytherapies anticancereuses
WO2008063808A3 (fr) Nanostructures amphiphiles peptidiques encapsulées
EP1758595A4 (fr) Utilisation de conjugues lipidiques dans le traitement de maladies
WO2003059916A8 (fr) Procedes de preparation d'alkyl diarylborinates et d'acides diarylboroniques complexes
EP1635764A4 (fr) Conjugue destine au ciblage specifique d'agents anticancereux sur des cellules cancereuses, et production du conjugue
IL187449A0 (en) Variants at chr8q24.21 confer risk of cancer
WO2004098524A3 (fr) Complexes de platine a lipides et leurs procedes d'utilisation
ZA200602386B (en) 5-Arylpyrimidines as anticancer agents
WO2007016352A3 (fr) Compositions orales liquides de losartan
WO2005079396A3 (fr) Complexes de o,o'-amidomalonate and n,o-amidomalonate platine
WO2007067784A3 (fr) Compositions liposomales
USD567232S1 (en) Push-to-talk communicator housing
PL1715851T3 (pl) Dostosowane dla konsumenta postacie dawki
EP1795182A4 (fr) Liposome améliorant l'administration intracellulaire de médicaments
WO2007140804A8 (fr) Procédé de préparation d'un oxaliplatine
NO20063418L (no) Konsumenttilpassede dosringsformer
GB2430408B (en) Decorative inlays
HK1101057A (en) Improved anticancer treatment
AU2004904700A0 (en) Improved anticancer treatment
ZA200710722B (en) Variants at Chr8q24.21 confer risk of cancer
TW200738130A (en) An ornamental receptacle and their preparation